Consultant in endocrinology and diabetes Professor Vinod Patel discusses current recommended pharmacological treatment ...

Tens of thousands of people with chronic kidney disease in England could be eligible for treatment with AstraZeneca's SGLT2 inhibitor Forxiga, after NICE backed NHS use of the drug in draft ...

AstraZeneca's Farxiga reduced the risk of hospitalisation ... Farxiga – known as Forxiga in some markets – has been beating a trail for the SLGT2 inhibitor class in heart failure, extending ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

AstraZeneca Pharma India Ltd., incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 17,519.38 Crore) operating in Pharmaceuticals sector. AstraZeneca Pharma India Ltd. key ...

After hours: February 14 at 7:52:35 PM EST Loading Chart for AZN ...

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is ...

After hours: February 14 at 7:52:35 PM EST ...